insights_auto
Why is SABS down 3.44%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
$2.81
arrow_downward
-3.44%(-0.10) 1D
$2.81
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 20, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
$2.79
High
$2.88
Low
$2.64
Mkt. cap
253.15M
Avg. vol.
709.90K
Volume
874.57K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
Open
$2.79
High
$2.88
Low
$2.64
Mkt. cap
253.15M
Avg. vol.
709.90K
Volume
874.57K
52-wk high
$5.15
52-wk low
$2.44
EPS
-$0.93
Beta
0.67
Shares outstanding
90.09M
No. of employees
86
News stories
From web sources and news partners
Traders Union
·
1 hour ago
VIX fear index hits highest level since April 2025 as S&P 500 plunges
Nacionale
·
5 hours ago
Is the stock market down for the year? Only the Nasdaq; the S&P 500 and Dow are barely up for 2026
FXStreet
·
11 hours ago
Dow Jones Industrial Average drops for a fifth day as AI rout widens
Big News Network.com
·
58 minutes ago
S&P 500 earnings growth projected to slow to 11% in 2027 as AI investment impulse peaks: Goldman Sachs
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Florida, United States
SectorHealth Care
IndustryBiotechnology
Websitesab.bio